| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Aggressive mast cell leukemia/sarcoma with CD4 expression and hemophagocytosis
|
Heimes Dillon, Anna L.
|
|
|
141 |
11 |
p. 1364
|
article
|
| 2 |
A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease
|
van Halteren, Astrid G. S.
|
|
|
141 |
11 |
p. 1277-1292
|
article
|
| 3 |
Back Matter
|
|
|
|
141 |
11 |
p. 1368
|
article
|
| 4 |
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor
|
Schavgoulidze, Anaïs
|
|
|
141 |
11 |
p. 1308-1315
|
article
|
| 5 |
Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy
|
Schnegg-Kaufmann, Annatina S.
|
|
|
141 |
11 |
p. 1316-1321
|
article
|
| 6 |
del(1p32), a powerful prognostic factor in myeloma
|
|
|
|
141 |
11 |
p. 1367
|
article
|
| 7 |
Del(1p32): prime time in (ultra) high-risk myeloma
|
Khot, Amit
|
|
|
141 |
11 |
p. 1241-1243
|
article
|
| 8 |
Determining venous thromboembolism risk in patients with adult-type diffuse glioma
|
Burdett, Kirsten Bell
|
|
|
141 |
11 |
p. 1322-1336
|
article
|
| 9 |
Diffuse myocardial fibrosis occurs in young patients with sickle cell anemia despite early disease-modifying therapy
|
Morin, Cara E.
|
|
|
141 |
11 |
p. 1358-1362
|
article
|
| 10 |
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma
|
Flerlage, Jamie E.
|
|
|
141 |
11 |
p. 1293-1307
|
article
|
| 11 |
Editorial Board
|
|
|
|
141 |
11 |
p. vi
|
article
|
| 12 |
Good or bad cops: immune cells in aGVHD
|
Stary, Georg
|
|
|
141 |
11 |
p. 1238-1240
|
article
|
| 13 |
GVHD prophylaxis: use an ortho IL-2/IL-2Rβ Treg system!
|
Wolf, Dietlinde
|
|
|
141 |
11 |
p. 1246-1247
|
article
|
| 14 |
Heart failure in SCA: still challenging
|
Hammoudi, Nadjib
|
|
|
141 |
11 |
p. 1248-1249
|
article
|
| 15 |
How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL
|
Myers, Regina M.
|
|
|
141 |
11 |
p. 1251-1264
|
article
|
| 16 |
Lew TE, Tam CS, Seymour JF. How I treat chronic lymphocytic leukemia after venetoclax. Blood. 2021;138(5):361-369.
|
|
|
|
141 |
11 |
p. 1366
|
article
|
| 17 |
Low-grade follicular lymphoma with extensive marginal zone differentiation and expression of MUM1 and CD30
|
Baykara, Yigit
|
|
|
141 |
11 |
p. 1363
|
article
|
| 18 |
Masthead Subscription
|
|
|
|
141 |
11 |
p. i
|
article
|
| 19 |
MDM2 and BCL-2: to p53 or not to p53?
|
Wang, Eunice S.
|
|
|
141 |
11 |
p. 1237-1238
|
article
|
| 20 |
Prevention of acute GVHD using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T cells in vivo
|
Ramos, Teresa L.
|
|
|
141 |
11 |
p. 1337-1352
|
article
|
| 21 |
Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL
|
Simonin, Mathieu
|
|
|
141 |
11 |
p. 1353-1358
|
article
|
| 22 |
Steffin DHM, Muhsen IN, Hill LC, et al. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022;140(1):16-24.
|
|
|
|
141 |
11 |
p. 1366
|
article
|
| 23 |
Summiting thrombotic hazards in glioma
|
Goshua, George
|
|
|
141 |
11 |
p. 1245-1246
|
article
|
| 24 |
Table of Contents
|
|
|
|
141 |
11 |
p. iii-v
|
article
|
| 25 |
Testi AM, Pession A, Diverio D, et al. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood. 2018;132(4):405-412.
|
|
|
|
141 |
11 |
p. 1365
|
article
|
| 26 |
The kids are alright: MDS clones mature
|
Rao, Sridhar
|
|
|
141 |
11 |
p. 1243-1245
|
article
|
| 27 |
Unraveling family ties in Hodgkin lymphoma
|
Fox, Lucy C.
|
|
|
141 |
11 |
p. 1240-1241
|
article
|
| 28 |
Vaxman I, Gertz MA. How I approach smoldering multiple myeloma. Blood. 2022;140(8):828-838.
|
|
|
|
141 |
11 |
p. 1366
|
article
|
| 29 |
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
|
Daver, Naval G.
|
|
|
141 |
11 |
p. 1265-1276
|
article
|
Journal description